Next Investors logo grey

How (and why) companies are mixing Terpenes into Cannabis Distillates

Published 29-MAY-2020 09:55 A.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

As medical research continues to establish the benefits of natural medicine, terpenes have truly come into their own within the American mainstream. Multiple industry mainstays from aromatherapy studios to gourmet chefs now use terpenes as commonly as they do other plant extracts and byproducts.

Cannabis enthusiasts purchase terps and incorporate them into everything from homemade brownies to vape juice. But there’s one industry that’s had surprisingly less of a symbiotic relationship with terpenes than anyone might have expected; namely the cannabis industry.

This odd lack of synergy is set to change however, with the rising popularity of cannabis distillates. As distillates gain popularity within the cannabis industry as well as with consumers, the practice of adding terpenes to distillate is quickly becoming increasingly common among both product manufacturers and hobbyists.

What are Cannabis Distillates?

In a nutshell, distillates are cannabis extracts consisting of a single compound or cannabinoid, with all secondary plant matter and materials completely stripped out by one of a variety of systematic processes.

The two most prominently-produced distillates within the industry today are tetrahydrocannabinol (THC) and cannabidiol (CBD) distillates, the former being the cannabis plant’s primary compound and the latter being its most abundant cannabinoid.

Distillates are significantly more potent than garden-variety cannabis oil and have mostly been used on their own as a base ingredient for things like edibles and vape cartridges. They’re also commonly used as a means of cannabis infusion into other goods or products.

However, the industry is now experimenting with incorporating specific terpenes back into distillates at lower percentages — or in precise terpene-to-distillate ratios — to create superior products with substantial increases in potency and health-positive benefits.

How DIYers Are Adding Terpenes to Distillates

While product manufacturers within the cannabis industry have much more sophisticated equipment at their disposal, it’s quite possible to incorporate terpenes into distillate with everyday items. All that’s needed is a dab tool (more commonly known as a “dabber”), a wide beaker and a magnetic hot plate equipped with a stirrer.

Natural as well as synthetic terpenes are available for sale both at brick-and-mortar dispensaries and online. After purchase of the desired terpene(s) and distillate, the process of making a passable infusion is fairly straightforward.

First, it’s worth noting that the terpenes to distillate ratio will significantly affect not only flavor and aroma, but viscosity as well. A lower percentage is usually recommended; typically between three to fifteen percent.

Once the desired amount of distillate is in the beaker, it is heated to approximately 110°F. The terpenes are then thoroughly mixed in with the dab tool for a period of two to three minutes. Once the mixture is sufficiently uniform, the magnetic stirrer is used to continue mixing for at least another three minutes — after which the final, infused distillate can be bottled or loaded in vape cartridges. The stirrer is usually allowed to continue during the bottling process, as it ensures even distribution of components and temperature throughout.

The Positive Effects of Adding Terpenes to Distillates

Unsurprisingly, there’s more to terpene infusion than simply getting distillates to taste fruity. After breaking down and isolating various compounds that make up cannabis oil, the isolated components can then be reformulated into fully customised blends available nowhere else on the market. The three most notable benefits to adding terpenes to distillates are, in no particular order:

  • Full Control Over Flavor & Aroma It’s worth noting that distillates retain no flavors or aromas whatsoever from the cannabis plant. By using terpenes such as Limonene (Citrus), Pinene (Pine) or Linalool (Floral), product manufacturers and hobbyists alike are able to fully tailor the scent and flavor profiles of their desired final distillate.
  • The Entourage Effect The Entourage Effect is a proposed mechanism by which cannabinoids and terpenoids work in tandem to essentially enhance each other’s effects via their modulatory interaction with the endocannabinoid system. By integrating terpenes in say, CBD distillates, product manufacturers and DIYers, can significantly increase their distillate’s medicinal and therapeutic potential.
  • Complementary Cannabis Strains for Desired Purposes Distillates can be geared toward specific indications with the use of terpenes derived from select cannabis strains. Blue Dream, for example, is famous for its ability to increase appetite while providing palpable relief from aches and pains — making its terpenes ideal for incorporation with THC or CBD distillates, to create products perfect for recuperating athletes.

Because of the added benefits and impressive versatility that comes with terpene infusion, it’s quite likely that terpene-infused distillates will become much more prevalent in the future, particularly in terms of consumer demand.

This article was first published at True-Blue.co'.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.